Documents | Ramucirumab for treating advanced gastric cancer or gastro–oesophageal junction adenocarcinoma previously treated with chemotherapy | Guidance | NICE

Documents

A list of downloadable documents created during development.

Expected publication

Equality Impact Assessment (Guidance development) 29 April 2016 173.19 KB

Final appraisal determination

Final appraisal determination
Final appraisal determination document 26 November 2015 446.13 KB
Committee papers 26 November 2015 1.08 MB

Appraisal consultation

Appraisal consultation
Committee papers information
Committee papers 15 September 2015 9.3 MB
Appraisal consultation document 15 September 2015 434.07 KB

Final scope

Final scope 16 March 2015 95.12 KB

Final matrix

Final matrix 05 August 2015 34.84 KB

NICEs response to comments on the draft scope and provisional matrix

NICEs response to comments on the draft scope and provisional matrix 16 March 2015 147.81 KB

Equality impact assessment

Equality impact assessment 16 March 2015 120.43 KB

Gastric cancer (metastatic) - ramucirumab (after chemotherapy): provisional matrix (pre-referral) July 2014

Gastric cancer (metastatic) - ramucirumab (after chemotherapy): provisional matrix (pre-referral) July 2014 06 February 2015 102.16 KB

Gastric cancer (metastatic) - ramucirumab (after chemotherapy): draft scope for consultation (pre-referral) July 2014

Gastric cancer (metastatic) - ramucirumab (after chemotherapy): draft scope for consultation (pre-referral) July 2014 06 February 2015 105.37 KB